Medtech product approvals drop in Australia

04/17/2013 | Clinica (subscription required)

The number of new medtech products approved in Australia declined throughout the last quarter of 2012 and first quarter of 2013, and the trend is expected to continue if the government sets stricter standards for higher risk products. The Therapeutic Goods Administration has proposed increasing pre-market scrutiny of medical devices and making its decision-making process more transparent, which could lead to delayed approvals.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ